Literature DB >> 4531031

Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus.

W Ostertag, G Roesler, C J Krieg, J Kind, T Cole, T Crozier, G Gaedicke, G Steinheider, N Kluge, S Dube.   

Abstract

Thymidine kinase positive (TK(+)) N type cell lines that had been transformed by spleen focus-forming virus were established by transformation with NB tropic Friend virus complex. Thymidine kinase deficient (TK(-)) cell clones were isolated. Some of these cell clones release 1000- to 100,000-fold reduced amounts of Friend virus complex as compared to the TK(+) parental cell clone. TK(-) clones were grown in medium without BrdUrd. Some of these TK(-) clones can be induced to release endogenous helper virus and transforming spleen focus-forming virus on reexposure to 10(-6)-10(-4) M BrdUrd. The induced Friend virus complex is of N host range as expected with induced endogenous virus in N-type cells. Before the induction of the endogenous virus spleen focus-forming virus complex, an induction of thymidine kinase (ATP:thymidine 5'-phosphotransferase, EC 2.7.1.75) activity is observed. The latter is possibly a prerequisite for the induction of endogenous virus in TK(-) cells. Induction of thymidine kinase activity and of endogenous virus is transient and always correlated. The role of BrdUrd and another thymidine analogue, azidothymidine, in interfering with C-type virus release in virus positive cells is discussed. Azidothymidine is unable to induce endogenous virus. Induction of endogenous virus by BrdUrd and inhibition of virus release in virus positive cells is apparently not caused by the same mechanism.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4531031      PMCID: PMC434023          DOI: 10.1073/pnas.71.12.4980

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  QUANTITATION OF A MURINE LEUKEMIA VIRUS WITH A SPLEEN COLONY ASSAY.

Authors:  D H PLUZNIK; L SACHS
Journal:  J Natl Cancer Inst       Date:  1964-09       Impact factor: 13.506

2.  MUTANT STRAINS OF HERPES SIMPLEX DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY.

Authors:  D R DUBBS; S KIT
Journal:  Virology       Date:  1964-04       Impact factor: 3.616

3.  ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE.

Authors:  A A AXELRAD; R A STEEVES
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

4.  Induction of thymidine kinase by vaccinia-infected mouse fibroblasts.

Authors:  S KIT; L J PIEKARSKI; D R DUBBS
Journal:  J Mol Biol       Date:  1963-01       Impact factor: 5.469

5.  A graded-response assay for the Friend leukemia virus.

Authors:  W P ROWE; I BRODSKY
Journal:  J Natl Cancer Inst       Date:  1959-12       Impact factor: 13.506

6.  Derivation of TK- clones from revertant TK+ mammalian cells.

Authors:  D J Roufa; B N Sadow; C T Caskey
Journal:  Genetics       Date:  1973-11       Impact factor: 4.562

7.  A virus-specific thymidine kinase in BHK-21 cells infected with herpes simplex virus.

Authors:  H G Klemperer; G R Haynes; W I Shedden; D H Watson
Journal:  Virology       Date:  1967-01       Impact factor: 3.616

8.  Moloney leukaemia virus as a helper in retrieving Friend virus from a non-infectious reticulum cell sarcoma.

Authors:  A H Fieldsteel; C Kurahara
Journal:  Nature       Date:  1969-09-20       Impact factor: 49.962

9.  [A simple method for the direct preparation of O2,3'-cyclo-2'-desoxynucleosides].

Authors:  G Kowollik; K Gaertner; P Langen
Journal:  Tetrahedron Lett       Date:  1969-09       Impact factor: 2.415

10.  Ribonucleic acid components of murine sarcoma and leukemia viruses.

Authors:  J Maisel; V Klement; M M Lai; W Ostertag; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

View more
  28 in total

Review 1.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

Review 2.  Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.

Authors:  E G Sandström; J C Kaplan
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

3.  Induction of interferon and erythropoietic differentiation in cells transformed by Friend virus.

Authors:  P Swetly
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

4.  Structural investigation of protonated azidothymidine and protonated dimer.

Authors:  Blake E Ziegler; Rick A Marta; Michael B Burt; Sabrina M Martens; Jonathan K Martens; Terry B McMahon
Journal:  J Am Soc Mass Spectrom       Date:  2013-12-04       Impact factor: 3.109

5.  Size, subunit composition, and secondary structure of the Friend virus genome.

Authors:  S Dube; H J Kung; W Bender; N Davidson; W Ostertag
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

Review 6.  Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).

Authors:  E Sandström; B Oberg
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

Review 7.  Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.

Authors:  J Balzarini
Journal:  Pharm World Sci       Date:  1994-04-15

Review 8.  The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

Authors:  Samuel Broder
Journal:  Antiviral Res       Date:  2009-12-16       Impact factor: 5.970

Review 9.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  H D Langtry; D M Campoli-Richards
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 10.  Design of some nucleic acid antimetabolites: expectations and reality.

Authors:  J P Horwitz
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.